AisedPro
One company.
Multiple SaaS engines.
We design, ship, and scale India-first software products across compliance, commerce, operations, healthcare quality, markets, and generative media — built for durable compound growth.
Product portfolio
Live SaaS products investors can evaluate today
Each product targets a clear Indian market wedge, ships independently, and feeds shared platform capability over time.
-
Open product
Accrevia
Hospital accreditation compliance platform — audits, standards, and quality workflows for NABH-aligned healthcare organizations.
-
Open product
LicenseHub
Catalog of 500+ Indian business registrations — GST, FSSAI, Udyam, trade licences — with documents, fees, and timelines for founders and operators.
-
Open product
MockView
AI mock interview practice — register, verify, and rehearse interviews with structured feedback for job seekers.
-
Open product
GrabDeals
Coupons, cashback, and affiliate commerce hub — high-intent shopping demand across ecommerce, insurance, travel, and brand promotions.
-
Open product
NeuroBloom
AI digital detox companion — urge interrupts, mood tracking, healthy replacements, and dopamine reset workflows for calmer focus.
-
Open product
GrowAxis
Full ERP & CRM stack for growing businesses — contacts, pipeline, inventory, sales, purchases, and invoicing in one operating system.
-
Open product
Algo Trading
NSE algo trading with Zerodha connectivity — backtests, automated strategies, and paper/live execution for systematic traders.
-
Open product
Video Studio
Long-form and short-form video generation on Google Cloud Vertex Veo, with an AI prompt builder for production-ready creative output.
-
Open product
Biography Studio
Multi-step creative pipeline orchestration — research, script, character, storyboard, image, and video in a coordinated production flow.
Investment thesis
Why a multi-product SaaS company compounds
Indian SMBs, hospitals, traders, and creators still run on fragmented tools. AisedPro attacks adjacent wedges with focused products, then consolidates identity, billing, analytics, and distribution into a shared platform layer.
- Portfolio diversification Revenue and learning across compliance, commerce, ERP, healthcare, fintech, and AI media — not a single-point product bet.
- India-first distribution Products speak local regulation, payment habits, and operating language — higher retention potential than generic global templates.
- Shared technical leverage Cloud infrastructure, auth patterns, and generative AI capabilities reuse across studios and business apps.
Product roadmap
Where the portfolio is headed
Near-term depth in live products, then platform unification and new category entries.
-
Now — H2 2026
Depth & product quality
Deepen LicenseHub guides for founders and consultants, expand GrabDeals affiliate coverage, harden GrowAxis/Accrevia for paying teams, and grow trading + studio usage loops.
- Cross-product analytics instrumentation
- Offer depth for top ecommerce & bank partners
- Enterprise onboarding for ERP & hospital compliance
-
2026 — 2027
Platform layer
Unified AisedPro identity, billing, and partner APIs so products share customers without forcing a monolith UX.
- Single sign-on across portfolio apps
- Usage-based billing & partner settlements
- Public API surface for selected modules
-
2027+
New category engines
Launch adjacent products on the shared stack — voice AI (Omnivoice), white-label compliance/ERP, and an SMB data graph connecting registrations, commerce, and operations.
- Omnivoice conversational product line
- White-label GrowAxis & Accrevia for channel partners
- India SMB operating graph across products
For investors
Built to show traction, not slideware
Live URLs below are production surfaces — navigate each product, review roadmap milestones, and request a deeper brief.
- Active products
- 7 live
- Focus markets
- India SMB · Health · Markets · Media
- Delivery model
- Cloud SaaS · Multi-app portfolio
- Stage signal
- Shipping & iterating in public
Contact
Let’s talk products, partnerships, or capital
Reach AisedPro for product demos, commercial partnerships, or investor conversations.